Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: Implication of reconstituted tumor microenvironment and multidrug resistance phenotype

These observations indicate that orlistat could be utilized as an adjunct regimen for improving antitumor efficacy of cisplatin.